US bill seeks drug, device user fees exemption
This article was originally published in Clinica
Executive Summary
A bipartisan group of US lawmakers on 18 July introduced a bill seeking to exempt industry-paid user fees from the across-the-board sequestration spending cuts to the Food and Drug Administration's budget.